Premium Information is available for this item - Upgrade for $1 a day

6505-01-300-2115

Usp Ceftazidime For Injection

6505013002115 013002115 K5086-11 MA 89-288

6505-01-300-2115 CEFTAZIDIME FOR INJECTION,USP 6505013002115 013002115

Managed by United States
NSN Created on 11 May 1989
Data Last Changed
January 2023
NATO Update Count
6
NATO Data Quality
6505-01-300-2115 CEFTAZIDIME FOR INJECTION,USP 6505013002115 013002115 1/1
NSN 6505-01-300-2115 (Generic Image) 1/1

6505-01-300-2115 Stock and Availability Marketplace 6505-01-300-2115

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-300-2115 RQST NE eBay
eBay Updated Every Day
6505-01-300-2115 RQST eBay
Amazon Updated Every Day
6505-01-300-2115 RQST NE Amazon

6505-01-300-2115 Related Documents Related Documents 6505-01-300-2115 3+ Documents (More...)

Documents 6505-01-344-5259 3+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-300-2115
Usp Ceftazidime For Injection 6505013002115 https//www.nsnlookup.com /nato/nato-stock-numbers/inc
6505-01-344-5259 Usp Ceftazidime For Injection CEPTAZRNCC: 5 | RNVC: 1 | DAC: 4 30 Aug 1991 6505-01-300-2115
01-301-3789 Usp Clindamycin Injection NDC00074-4054-03RNCC: 3 | RNVC: 2 | DAC: 6 27 May 1989 6505-01-300-2115

6505-01-300-2115 Demil Restrictions 6505-01-300-2115

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC: 0

6505-01-300-2115 is a Usp Ceftazidime For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-01-300-2115 HTS and ScheduleB Import and Export 6505-01-300-2115

6505-01-300-2115 End Users End Users 6505-01-300-2115

MOE Rule:
V542
Effective Date:
1 Apr 1991

6505-01-300-2115 Manufacturers Approved Sources 6505-01-300-2115

6505-01-300-2115 Technical Data Datasheet 6505-01-300-2115

Characteristic
Specifications
FIIG
A34300
Active Medicament Medicinal Strength [AKJA]
6.000 Grams Ceftazidime, Anhydrous Equivalent
Administration [CSGS]
Intramuscular Or Intravenous
Primary Container Content Quantity [CRLK]
6.000 Grams Of Active Ingredient
Primary Container Type [CQCT]
Vial, Multiple Dose
Part Name Assigned By Controlling Agency [CXCY]
Ceftazidime For Injection
Physical Form [AGXW]
Powder
Special Features [FEAT]
Each Vial Contains Ceftazidime Pentahydrate Equivalent To 6 Grams Of Ceftazidime,And 118 Milligrams Sodium Carbonate Per Gram Of Ceftazidime; Pharmacy Bulk Pack

6505-01-300-2115 Management Data Management Data 6505-01-300-2115

Effective Date
Organization
Unit of Issue
Unit Price
Qty Unit Pack
Jul 1990
Veterans Administration (VA)
VI
Subscribe
MOE
USC
Code
Statement
Order of Use
Jump To Code
Qty Per Assy
UOM
Technical Document
Quantative Expression
Veterans Administration (VA)
V
K
U/I Contains 6 Gm
00000000006GM

6505-01-300-2115 Related Items NATO Stock Numbers Related to 6505-01-300-2115

6505-01-300-2115 Freight Data Freight Information 6505-01-300-2115

6505-01-300-2115 has freight characteristics.. 6505-01-300-2115 has a variance between NMFC and UFC when transported by rail and the description should be consulted.